Protein expression and mutational analysis of epidermal growth factor receptor in renal angiomyolipomas

Pathology International

Volumn 57, Issue 9, 2007, Pages 584-588

  Lim, So Dug ^a,b   Kim, Wanseop ^a   Ahn, Geunghwan ^c   Kwon, Ghee Young ^c,d  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

Author keywords

Angiomyolipoma; Epidermal growth factor receptor; Immunohistochemistry; Kidney; Mutation; Pyrosequencing

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ANGIOMYOLIPOMA; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY HEMANGIOMYOLIPOMA; KIDNEY TUMOR; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR GENE;

ADULT; AGED; ANGIOMYOLIPOMA; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 34547701740     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02142.x     Document Type: Article

References (21)

1. Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol 1998 15 : 21 40.
2. L'Hostis H, Deminiere C, Ferriere JM, Coindre JM. Renal angiomyolipoma: A clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol 1999 23 : 1011 20.
3. Bonetti F, Pea M, Martignoni G et al. Clear cell ('sugar') tumor of the lung is a lesion strictly related to angiomyolipoma: The concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 1994 26 : 230 36.
4. Astrinidis A, Henske EP. Tuberous sclerosis complex: Linking growth and energy signaling pathways with human disease. Oncogene 2005 24 : 7475 81.
5. Zhuang S, Yan Y, Han J, Schnellmann RG. p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury. J Biol Chem 2005 280 : 21 36 42.
6. Sawyers C. Targeted cancer therapy. Nature 2004 432 : 294 7.
7. Mendelsohn J, Baselga J. Epidermal growth factor receptor targeting in cancer. Semin Oncol 2006 33 : 369 85.
8. Yarden Y. The EGFR family and its ligands in human cancer: Signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001 37 : S3 8.
9. Sugio K, Uramoto H, Ono K et al. Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking. Br J Cancer 2006 94 : 896 903.
10. Lesma E, Grande V, Carelli S et al. Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: Epidermal growth factor is the required growth factor. Am J Pathol 2005 167 : 1093 103.
11. Schroeder M, Aul C, Coulier B, Vander Elst B. Anti-angiogenic therapy of a renal angiomyolipoma in a seriously disabled patient suffering from multiple sclerosis [Giant and bilateral renal angiomyolipomas]. Aktuelle Urol 2005 36 : 430 32.
12. Esmaeli B, Prieto VG, Gonnering R et al. Growth factor receptor expression in orbital lymphangioma: Possible therapeutic implications. Orbit 2004 23 : 263 9.
13. Tuohy MJ, Hall GS, Sholtis M, Procop GW. Pyrosequencing as a tool for the identification of common isolates of Mycobacterium sp. Diagn Microbiol Infect Dis 2005 51 : 245 50.
14. Choi JE, Chae JH, Hwang YS, Kim KJ. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex. Brain Dev 2006 28 : 440 46.
15. Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004 350 : 2129 39.
16. Gazdar AF, Shigematsu H, Herz J, Minna JD. Mutations and addiction to EGFR: The Achilles 'heal' of lung cancers? Trends Mol Med 2004 10 : 481 6.
17. Paez JG, Janne PA, Lee JC et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 2004 304 : 1497 500.
18. Suzuki E, Sasaki H, Kawano O et al. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors. Jpn J Clin Oncol 2006 36 : 351 6.
19. Lee JW, Soung YH, Kim SY et al. Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. Int J Cancer 2005 113 : 510 11.
20. Dacic S, Flanagan M, Cieply K et al. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Am J Clin Pathol 2006 125 : 860 65.
21. Petit AM, Rak J, Hung MC et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 1997 151 : 1523 30.